Ranunculus bulbosus (Laboratoires Boiron)


Welcome to the PulseAid listing for the Ranunculus bulbosus drug offered from Laboratoires Boiron. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Laboratoires Boiron
NON-PROPRIETARY NAME: RANUNCULUS BULBOSUS
SUBSTANCE NAME: RANUNCULUS BULBOSUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1983-03-03
END MARKETING DATE: 0000-00-00


Ranunculus bulbosus HUMAN OTC DRUG Details:

Item DescriptionRanunculus bulbosus from Laboratoires Boiron
LABELER NAME: Laboratoires Boiron
DEA SCHEDULE:
ACTIVE STRENGTH: 6([hp_C]/1)
START MARKETING DATE: 1983-03-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0220-4317_f794b8d0-7c6c-11e6-8847-424c58303031
PRODUCT NDC: 0220-4317
APPLICATION NUMBER:

Other RANUNCULUS BULBOSUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laboratoires BoironRanunculus bulbosus
Paramesh Banerji Life Sciences LLCRanunculus bulbosus 30C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncRANUNCULUS BULBOSUS
Washington Homeopathic ProductsRanunculus Bulbosus